Comparison of Hemodynamic Effects of Two Modalities of Alveolar Recruitment Maneuvers in Major Abdominal Surgery Patients
CHARM-Bloc
1 other identifier
interventional
20
1 country
1
Brief Summary
The objective of this study is to investigate the hemodynamic effects of two strategies of alveolar recruitment maneuver in patients undergoing major abdominal surgery in the operating room
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 9, 2022
CompletedFirst Submitted
Initial submission to the registry
April 19, 2022
CompletedFirst Posted
Study publicly available on registry
May 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedJune 18, 2023
June 1, 2023
3 months
April 19, 2022
June 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The primary outcome measure is the change in cardiac output during the last 10 seconds of each MRA modality from its baseline value (determined after hemodynamic optimization and before the procedure was performed)
Cardiac output (l/min) will be measured by invasive monitoring during the last 10 seconds of each recruitment maneuver
last 10 seconds of each ARM modality
Secondary Outcomes (16)
Standard hemodynamic monitoring data
last 10 seconds of each ARM modality
Standard hemodynamic monitoring data
last 10 seconds of each ARM modality
Invasive hemodynamic monitoring data
last 10 seconds of each ARM modality
Invasive hemodynamic monitoring data
last 10 seconds of each ARM modality
Evaluation of standard ventilatory monitoring data
last 10 seconds of each ARM modality
- +11 more secondary outcomes
Study Arms (2)
Continuous positive airway pressure (CPAP) then extended sigh
ACTIVE COMPARATORPatients assigned to this group will receive a CPAP ARM (40cmH2O during 50 seconds), followed by a 10-minute pause corresponding to a period of return to basal state. Then an ARM by extended sigh (e-sigh) also 50 seconds (driving pressure at 10cmH2O and successive PEEP levels at 10, 15, 20, 25 and 30cmH2O, with respiratory frequency fixed at 30/min in controlled pressure). Hemodynamic (blood pressure, cardiac output, stroke volume) and ventilatory measurements will be performed the last 10 seconds of each recruitment maneuver.
extended sigh then continuous positive airway pressure (CPAP)
ACTIVE COMPARATORPatients assigned to this group will receive an ARM by extended sigh (e-sigh) during 50 seconds (driving pressure at 10cmH2O and successive PEEP levels at 10, 15, 20, 25 and 30cmH2O, with respiratory frequency fixed at 30/min in controlled pressure), followed by a 10-minute pause corresponding to a period of return to basal state. Then they receive a CPAP ARM (40cmH2O during 50 seconds). Hemodynamic (blood pressure, cardiac output, stroke volume) and ventilatory measurements will be performed the last 10 seconds of each recruitment maneuver.
Interventions
When patient is under general anesthesia, an arterial catheter is placed for cardiac output and stroke volume (SV) monitoring. To avoid pre-load dependency bias, the blood volume will be optimized. A 250mL fluid-challenge of a balanced crystalloid solution is administered under cover of the SV monitoring. If SV variation is greater than 10%, a new fluid-challenge is performed to obtain a reference SV, corresponding to the patient's optimal blood volume.The patient is then "pre-load independent". Then, patients will be randomized into two groups: a first group will receive a CPAP ARM: 40 cmH2O for 50 seconds, followed by a 10-minute break corresponding to a period of return to basal state; then an extended sigh ARM (e-sigh) also lasting 50seconds (driving pressure: 10cmH2O and successive PEEP levels at 10,15,20,25 and 30cmH2O, a respiratory rate set at 30/min in controlled pressure - 5cycles at each PEEP level); a second group will receive the same two ARM modalities in reverse order.
Eligibility Criteria
You may qualify if:
- patient over 18 years old
- patient under general anesthesia
- patient intubated under controlled invasive mechanical ventilation
- patient with invasive hemodynamic monitoring (transpulmonary thermodilution)
- patient sedated (BIS between 40 and 60) and/or curarized with TOF monitoring to avoid inspiratory effort
- patient optimized on the hemodynamic level, in particular with regard to blood volume, following the hemodynamic monitoring data and the recommendations of the French Society of Anesthesia and Resuscitation (RFE SFAR 2013 - Perioperative vascular filling strategy)
- patient covered by a Social Security plan
- patient consent to participate in the study
You may not qualify if:
- contraindication to the use of cardiac output measurement
- cardiac arrhythmia
- pace-maker/implantable defibrillator
- severe valvulopathy
- contraindication to the use of the tomographic electroimpedancemetry technique
- thoracic lesions, thoracic dressing
- left ventricular ejection fraction (LVEF) \< 45% and/or right ventricular failure.
- history of pulmonary lobectomy and/or pneumonectomy and/or known emphysema
- patient with restrictive or obstructive lung disease
- body mass index (BMI) \< 16.5 or \> 30 kg.m-2
- pregnancy
- intracranial hypertension or suspected intracranial hypertension
- patient under limitation of care
- patient under legal protection (guardianship, curatorship, safeguard of justice)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU
Clermont-Ferrand, 63000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 19, 2022
First Posted
May 9, 2022
Study Start
March 9, 2022
Primary Completion
May 31, 2022
Study Completion
May 31, 2022
Last Updated
June 18, 2023
Record last verified: 2023-06